{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:50:47Z","timestamp":1789678247320,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["24-11903S"],"award-info":[{"award-number":["24-11903S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["24-11903S"],"award-info":[{"award-number":["24-11903S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["24-10672S"],"award-info":[{"award-number":["24-10672S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Cancer Research","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}]},{"name":"National Institute for Cancer Research","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}]},{"name":"National Institute for Cancer Research","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation program","award":["955708"],"award-info":[{"award-number":["955708"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation program","award":["955708"],"award-info":[{"award-number":["955708"]}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"crossref","award":["VI.Vidi.213.139"],"award-info":[{"award-number":["VI.Vidi.213.139"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33902-x","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:17:27Z","timestamp":1767493047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Migrastatic therapy as a potential game-changer in adaptive cancer treatment"],"prefix":"10.1038","volume":"16","author":[{"given":"Katharina","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Spekking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepinoud","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Peltanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"R\u00f6sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Gatenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Br\u00e1bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Sta\u0148kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"33902_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/CNCR.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer127, 3029\u20133030. https:\/\/doi.org\/10.1002\/CNCR.33587 (2021).","journal-title":"Cancer"},{"key":"33902_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/S41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh, K. & Massagu\u00e9, J. Targeting metastatic cancer. Nat. Med.27, 34\u201344. https:\/\/doi.org\/10.1038\/S41591-020-01195-4 (2021).","journal-title":"Nat. Med."},{"key":"33902_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/NM.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan, L., Pantel, K. & Kang, Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med.19, 1450\u20131464. https:\/\/doi.org\/10.1038\/NM.3391 (2013).","journal-title":"Nat. Med."},{"key":"33902_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/459508a","volume":"459","author":"RA Gatenby","year":"2009","unstructured":"Gatenby, R. A. A change of strategy in the war on cancer. Nature459, 508\u2013509. https:\/\/doi.org\/10.1038\/459508a (2009).","journal-title":"Nature"},{"key":"33902_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/eva.13190","volume":"14","author":"AM Dujon","year":"2021","unstructured":"Dujon, A. M. et al. Identifying key questions in the ecology and evolution of cancer. Evol. Appl.14, 877\u2013892. https:\/\/doi.org\/10.1111\/eva.13190 (2021).","journal-title":"Evol. Appl."},{"key":"33902_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jnci\/85.3.217","volume":"85","author":"MJ Ratain","year":"1993","unstructured":"Ratain, M. J. & Mick, R. Model-guided determination of maximum tolerated dose in phase I clinical trials: A paradigm for dose selection in the era of targeted therapies. JNCI85, 217\u2013223. https:\/\/doi.org\/10.1093\/jnci\/85.3.217 (1993).","journal-title":"JNCI"},{"key":"33902_CR7","doi-asserted-by":"publisher","unstructured":"Gad, S. C. Maximum tolerated dose. In Encyclopedia of Toxicology, 43\u201344, https:\/\/doi.org\/10.1016\/B978-0-12-824315-2.00532-7 (Academic Press, Oxford, 2024), fourth edition edn.","DOI":"10.1016\/B978-0-12-824315-2.00532-7"},{"key":"33902_CR8","doi-asserted-by":"publisher","unstructured":"Cree, I. A. & Charlton, P. Molecular chess? Hallmarks of anti-cancer drug resistance. BMC Cancer 17. https:\/\/doi.org\/10.1186\/s12885-016-2999-1 (2017).","DOI":"10.1186\/s12885-016-2999-1"},{"key":"33902_CR9","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/S00018-008-8111-5","volume":"65","author":"H Lage","year":"2008","unstructured":"Lage, H. An overview of cancer multidrug resistance: a still unsolved problem. Cell. Mol. Life Sci.65, 3145\u20133167. https:\/\/doi.org\/10.1007\/S00018-008-8111-5 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"33902_CR10","doi-asserted-by":"publisher","unstructured":"Dini\u0107, J. et al. Repurposing old drugs to fight multidrug resistant cancers. Drug Res. Updates 100713, https:\/\/doi.org\/10.1016\/j.drup.2020.100713 (2020).","DOI":"10.1016\/j.drup.2020.100713"},{"key":"33902_CR11","doi-asserted-by":"publisher","unstructured":"Sta\u0148kov\u00e1, K. Resistance games. Nat. Ecol. Evolut. 3, 336\u2013337. https:\/\/doi.org\/10.1038\/s41559-018-0785-y (2019).","DOI":"10.1038\/s41559-018-0785-y"},{"key":"33902_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-20-0806","volume":"81","author":"M Strobl","year":"2021","unstructured":"Strobl, M. et al. Turnover modulates the need for a cost of resistance in adaptive therapy. Can. Res.81, 1135\u20131147. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0806 (2021).","journal-title":"Can. Res."},{"key":"33902_CR13","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","volume":"69","author":"RA Gatenby","year":"2009","unstructured":"Gatenby, R. A., Silva, A. S., Gillies, R. J. & Frieden, B. R. Adaptive therapy. Cancer Res.69, 4894. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3658 (2009).","journal-title":"Cancer Res."},{"key":"33902_CR14","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/0008-5472.CAN-19-2669","volume":"80","author":"J West","year":"2020","unstructured":"West, J. et al. Towards multidrug adaptive therapy. Cancer Res.80, 1578\u20131589. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2669 (2020).","journal-title":"Cancer Res."},{"key":"33902_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2025.09.034","author":"KA Luddy","year":"2025","unstructured":"Luddy, K. A. et al. Evolutionary double-bind treatment using radiotherapy and nk cell-based immunotherapy in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.034 (2025).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"33902_CR16","doi-asserted-by":"publisher","unstructured":"West, J. et al. A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation. eLife12, e84263, https:\/\/doi.org\/10.7554\/eLife.84263 (2023).","DOI":"10.7554\/eLife.84263"},{"key":"33902_CR17","doi-asserted-by":"publisher","first-page":"20192454","DOI":"10.1098\/rspb.2019.2454","volume":"287","author":"M Gluzman","year":"2020","unstructured":"Gluzman, M., Scott, J. G. & Vladimirsky, A. Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory. Proc. R. Soc. B287, 20192454. https:\/\/doi.org\/10.1098\/rspb.2019.2454 (2020).","journal-title":"Proc. R. Soc. B"},{"key":"33902_CR18","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1158\/0008-5472.can-25-0351","volume":"85","author":"H Hockings","year":"2025","unstructured":"Hockings, H. et al. Adaptive therapy exploits fitness deficits in chemotherapy-resistant ovarian cancer to achieve long-term tumor control. Can. Res.85, 3503\u20133517. https:\/\/doi.org\/10.1158\/0008-5472.can-25-0351 (2025).","journal-title":"Can. Res."},{"key":"33902_CR19","doi-asserted-by":"publisher","unstructured":"Gevertz, J. L. et al. Delaying cancer progression by integrating toxicity constraints in a model of adaptive therapy. bioRxiv 2025.04.24.650205, https:\/\/doi.org\/10.1101\/2025.04.24.650205 (2025).","DOI":"10.1101\/2025.04.24.650205"},{"key":"33902_CR20","doi-asserted-by":"publisher","unstructured":"Soboleva, A., Grossmann, I., Dingemans, A.-M. C., Rezaei, J. & Sta\u0148kov\u00e1, K. Bringing evolutionary cancer therapy to clinic through a systems approach. npj Syst. Biol. Appl. https:\/\/doi.org\/10.1038\/s41540-025-00528-8 (2025).","DOI":"10.1038\/s41540-025-00528-8"},{"key":"33902_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/S00285-024-02062-3","volume":"88","author":"FE Alvarez","year":"2024","unstructured":"Alvarez, F. E. & Viossat, Y. Tumor containment: a more general mathematical analysis. J. Math. Biol.88, 41. https:\/\/doi.org\/10.1007\/S00285-024-02062-3 (2024).","journal-title":"J. Math. Biol."},{"key":"33902_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/S41559-021-01428-W","volume":"5","author":"Y Viossat","year":"2021","unstructured":"Viossat, Y. & Noble, R. A theoretical analysis of tumour containment. Nat. Ecol. Evolut. 5, 826\u2013835. https:\/\/doi.org\/10.1038\/S41559-021-01428-W (2021).","journal-title":"Nat. Ecol. Evolut."},{"key":"33902_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/S13235-021-00397-W","volume":"12","author":"B W\u00f6lfl","year":"2022","unstructured":"W\u00f6lfl, B. et al. The contribution of evolutionary game theory to understanding and treating cancer. Dyn. Games Appl. 12, 313\u2013342. https:\/\/doi.org\/10.1007\/S13235-021-00397-W (2022).","journal-title":"Dyn. Games Appl."},{"key":"33902_CR24","doi-asserted-by":"publisher","unstructured":"Zhang, J., Cunningham, J. J., Brown, J. S. & Gatenby, R. A. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat. Commun.8, https:\/\/doi.org\/10.1038\/S41467-017-01968-5 (2017).","DOI":"10.1038\/S41467-017-01968-5"},{"key":"33902_CR25","doi-asserted-by":"publisher","unstructured":"Zhang, J., Cunningham, J. J., Brown, J. S. & Gatenby, R. A. Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes. eLife11, https:\/\/doi.org\/10.7554\/eLife.76284 (2022).","DOI":"10.7554\/eLife.76284"},{"key":"33902_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1158\/0008-5472.CAN-19-1941","volume":"80","author":"RA Gatenby","year":"2020","unstructured":"Gatenby, R. A., Artzy-Randrup, Y., Epstein, T., Reed, D. R. & Brown, J. S. Eradicating metastatic cancer and the eco-evolutionary dynamics of anthropocene extinctions. Cancer Res.80, 613\u2013623. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1941 (2020).","journal-title":"Cancer Res."},{"key":"33902_CR27","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ejca.2010.02.039","volume":"46","author":"J Sleeman","year":"2010","unstructured":"Sleeman, J. & Steeg, P. S. Cancer metastasis as a therapeutic target. Eur. J. Cancer 46, 1177\u20131180. https:\/\/doi.org\/10.1016\/j.ejca.2010.02.039 (2010).","journal-title":"Eur. J. Cancer"},{"key":"33902_CR28","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/CAM4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s, H., Rogers, M. S. & Straume, O. Are 90% of deaths from cancer caused by metastases?. Cancer Med.8, 5574\u20135576. https:\/\/doi.org\/10.1002\/CAM4.2474 (2019).","journal-title":"Cancer Med."},{"key":"33902_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trecan.2015.07.009","volume":"1","author":"AC Obenauf","year":"2015","unstructured":"Obenauf, A. C. & Massagu\u00e9, J. Surviving at a Distance: Organ-Specific Metastasis. Trends in Cancer1, 76\u201391. https:\/\/doi.org\/10.1016\/j.trecan.2015.07.009 (2015).","journal-title":"Trends in Cancer"},{"key":"33902_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/J.CELL.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging Biological Principles of Metastasis. Cell168, 670\u2013691. https:\/\/doi.org\/10.1016\/J.CELL.2016.11.037 (2017).","journal-title":"Cell"},{"key":"33902_CR31","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.neuron.2025.07.009","volume":"113","author":"EK Sloan","year":"2025","unstructured":"Sloan, E. K. & Chang, A. Wired to spread: Neural regulation of metastasis. Neuron113, 2726\u20132728. https:\/\/doi.org\/10.1016\/j.neuron.2025.07.009 (2025).","journal-title":"Neuron"},{"key":"33902_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/J.TRECAN.2019.10.011","volume":"5","author":"D R\u00f6sel","year":"2019","unstructured":"R\u00f6sel, D., Fernandes, M., Sanz-Moreno, V. & Br\u00e1bek, J. Migrastatics: Redirecting R&D in Solid Cancer Towards Metastasis?. Trends in cancer5, 755\u2013756. https:\/\/doi.org\/10.1016\/J.TRECAN.2019.10.011 (2019).","journal-title":"Trends Cancer"},{"key":"33902_CR33","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1158\/0008-5472.CAN-19-1147","volume":"79","author":"GS Karagiannis","year":"2019","unstructured":"Karagiannis, G. S., Condeelis, J. S. & Oktay, M. H. Chemotherapy-induced metastasis: Molecular mechanisms, clinical manifestations. Ther. Interv. Cancer Res.79, 4567\u20134576. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1147 (2019).","journal-title":"Ther. Interv. Cancer Res."},{"key":"33902_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","volume":"3","author":"A Gandalovi\u010dov\u00e1","year":"2017","unstructured":"Gandalovi\u010dov\u00e1, A. et al. Migrastatics\u2014anti-metastatic and anti-invasion drugs: Promises and challenges. Trends Cancer3, 391\u2013406. https:\/\/doi.org\/10.1016\/j.trecan.2017.04.008 (2017).","journal-title":"Trends Cancer"},{"key":"33902_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/J.TRECAN.2023.01.001","volume":"9","author":"M Raudensk\u00e1","year":"2023","unstructured":"Raudensk\u00e1, M. et al. Engine shutdown: migrastatic strategies and prevention of metastases. Trends Cancer9, 293\u2013308. https:\/\/doi.org\/10.1016\/J.TRECAN.2023.01.001 (2023).","journal-title":"Trends Cancer"},{"key":"33902_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/J.MOLMED.2024.04.003","volume":"30","author":"A \u0160karkov\u00e1","year":"2024","unstructured":"\u0160karkov\u00e1, A. et al. Educate, not kill: treating cancer without triggering its defenses. Trends Mol. Med.30, 673\u2013685. https:\/\/doi.org\/10.1016\/J.MOLMED.2024.04.003 (2024).","journal-title":"Trends Mol. Med."},{"key":"33902_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/S10585-018-9873-2","volume":"35","author":"C Behrenbruch","year":"2018","unstructured":"Behrenbruch, C. et al. Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process. Clin. Exp. Metas.35, 333\u2013345. https:\/\/doi.org\/10.1007\/S10585-018-9873-2 (2018).","journal-title":"Clin. Exp. Metas."},{"key":"33902_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jtbi.2018.07.014","volume":"455","author":"P Bayer","year":"2018","unstructured":"Bayer, P., Brown, J. S. & Sta\u0148kov\u00e1, K. A two-phenotype model of immune evasion by cancer cells. J. Theor. Biol.455, 191\u2013204. https:\/\/doi.org\/10.1016\/j.jtbi.2018.07.014 (2018).","journal-title":"J. Theor. Biol."},{"key":"33902_CR39","doi-asserted-by":"publisher","unstructured":"You, L. et al. Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model. J. Theor. Biol.435, 78\u201397, https:\/\/doi.org\/10.1016\/j.jtbi.2017.08.022 (2017).","DOI":"10.1016\/j.jtbi.2017.08.022"},{"key":"33902_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/1541-7786.MCR-16-0411","volume":"15","author":"BC Jones","year":"2017","unstructured":"Jones, B. C. et al. Dual targeting of mesenchymal and amoeboid motility hinders metastatic behavior. Mol. Cancer Res. MCR15, 670\u2013682. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0411 (2017).","journal-title":"Mol. Cancer Res. MCR"},{"key":"33902_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/S00418-016-1433-8","volume":"146","author":"NP Jobe","year":"2016","unstructured":"Jobe, N. P. et al. Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness. Histochem. Cell Biol.146, 205\u2013217. https:\/\/doi.org\/10.1007\/S00418-016-1433-8 (2016).","journal-title":"Histochem. Cell Biol."},{"key":"33902_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/S41416-021-01442-6","volume":"125","author":"O Maiques","year":"2021","unstructured":"Maiques, O. et al. A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma. Br. J. Cancer125, 699\u2013713. https:\/\/doi.org\/10.1038\/S41416-021-01442-6 (2021).","journal-title":"Br. J. Cancer"},{"key":"33902_CR43","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/CAM4.1697","volume":"7","author":"M Riihim\u00e4ki","year":"2018","unstructured":"Riihim\u00e4ki, M., Thomsen, H., Sundquist, K., Sundquist, J. & Hemminki, K. Clinical landscape of cancer metastases. Cancer Med.7, 5534\u20135542. https:\/\/doi.org\/10.1002\/CAM4.1697 (2018).","journal-title":"Cancer Med."},{"key":"33902_CR44","doi-asserted-by":"publisher","unstructured":"Henke, E., Nandigama, R. & Erg\u00fcn, S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front. Mol. Biosci.6, https:\/\/doi.org\/10.3389\/fmolb.2019.00160 (2020).","DOI":"10.3389\/fmolb.2019.00160"},{"key":"33902_CR45","doi-asserted-by":"publisher","first-page":"20220346","DOI":"10.1098\/rsif.2022.0346","volume":"19","author":"H Coggan","year":"2022","unstructured":"Coggan, H. & Page, K. M. The role of evolutionary game theory in spatial and non-spatial models of the survival of cooperation in cancer: a review. J. R. Soc. Interface19, 20220346. https:\/\/doi.org\/10.1098\/rsif.2022.0346 (2022).","journal-title":"J. R. Soc. Interface"},{"key":"33902_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040972","volume":"10","author":"RA Gatenby","year":"2020","unstructured":"Gatenby, R. A. & Brown, J. S. The evolution and ecology of resistance in cancer therapy. Cold Spring Harb. Perspect. Med.10, a040972. https:\/\/doi.org\/10.1101\/cshperspect.a040972 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"33902_CR47","doi-asserted-by":"publisher","first-page":"20130016","DOI":"10.1098\/rsfs.2013.0016","volume":"3","author":"J Gallaher","year":"2013","unstructured":"Gallaher, J. & Anderson, A. R. A. Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance. Interface Focus3, 20130016. https:\/\/doi.org\/10.1098\/rsfs.2013.0016 (2013).","journal-title":"Interface Focus"},{"key":"33902_CR48","doi-asserted-by":"publisher","first-page":"16103","DOI":"10.1073\/PNAS.1314385110","volume":"110","author":"A Wu","year":"2013","unstructured":"Wu, A. et al. Cell motility and drug gradients in the emergence of resistance to chemotherapy. Proc. Natl. Acad. Sci. U.S.A.110, 16103\u201316108. https:\/\/doi.org\/10.1073\/PNAS.1314385110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"33902_CR49","doi-asserted-by":"publisher","unstructured":"Pressley, M. et al. Evolutionary dynamics of treatment-induced resistance in cancer informs understanding of rapid evolution in natural systems. Front. Ecol. Evolut.9, https:\/\/doi.org\/10.3389\/fevo.2021.681121 (2021).","DOI":"10.3389\/fevo.2021.681121"},{"key":"33902_CR50","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s13235-025-00629-3","volume":"15","author":"M Satouri","year":"2025","unstructured":"Satouri, M., Rezaei, J. & Sta\u0148kov\u00e1, K. Stability of the Darwinian dynamics: Effect of intraspecific competition and human interventionDyn Games Appl.15, 1467\u20131493. https:\/\/doi.org\/10.1007\/s13235-025-00629-3 (2025).","journal-title":"Dyn. Games Appl."},{"key":"33902_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261578","volume":"17","author":"P Bayer","year":"2022","unstructured":"Bayer, P. et al. Coordination games in cancer. PLOS ONE17, e0261578. https:\/\/doi.org\/10.1371\/journal.pone.0261578 (2022).","journal-title":"PLOS ONE"},{"key":"33902_CR52","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/S13235-023-00520-Z","volume":"13","author":"P Bayer","year":"2023","unstructured":"Bayer, P. & West, J. Games and the treatment convexity of cancer. Dyn. Games Appl.13, 1088\u20131105. https:\/\/doi.org\/10.1007\/S13235-023-00520-Z (2023).","journal-title":"Dyn. Games Appl."},{"key":"33902_CR53","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41559-018-0768-z","volume":"3","author":"A Kaznatcheev","year":"2019","unstructured":"Kaznatcheev, A., Peacock, J., Basanta, D., Marusyk, A. & Scott, J. G. Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer. Nature Ecology & Evolution3, 450\u2013456. https:\/\/doi.org\/10.1038\/s41559-018-0768-z (2019).","journal-title":"Nat. Ecol. Evolut."},{"key":"33902_CR54","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.191578","volume":"7","author":"S Arbabi Moghadam","year":"2020","unstructured":"Arbabi Moghadam, S., Rezania, V. & Tuszynski, J. A. Cell death and survival due to cytotoxic exposure modelled as a two-state ising system. R. Soc. Open Sci.7, 191578. https:\/\/doi.org\/10.1098\/rsos.191578 (2020).","journal-title":"R. Soc. Open Sci."},{"key":"33902_CR55","doi-asserted-by":"publisher","unstructured":"Zhao, W. et al. The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest. Cell Death Disease14, https:\/\/doi.org\/10.1038\/s41419-022-05528-8 (2023).","DOI":"10.1038\/s41419-022-05528-8"},{"key":"33902_CR56","doi-asserted-by":"publisher","unstructured":"Gatenby, R. A., Zhang, J. & Brown, J. S. First strike \u2013 second strike strategies in metastatic cancer: Lessons from the evolutionary dynamics of extinction. Cancer Res.79, :3174\u20133177, https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0807 (2019).","DOI":"10.1158\/0008-5472.CAN-19-0807"},{"key":"33902_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtbi.2018.09.022","volume":"459","author":"JJ Cunningham","year":"2018","unstructured":"Cunningham, J. J., Brown, J. S., Gatenby, R. A. & Sta\u0148kov\u00e1, K. Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer. J. Theor. Biol.459, 67\u201378. https:\/\/doi.org\/10.1016\/j.jtbi.2018.09.022 (2018).","journal-title":"J. Theor. Biol."},{"key":"33902_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243386","volume":"15","author":"JJ Cunningham","year":"2020","unstructured":"Cunningham, J. J. et al. Optimal control to reach eco-evolutionary stability in metastatic castrate resistant prostate cancer. PLoS ONE15, e0243386. https:\/\/doi.org\/10.1371\/journal.pone.0243386 (2020).","journal-title":"PLoS ONE"},{"key":"33902_CR59","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s13235-024-00609-z","volume":"15","author":"M Salvioli","year":"2024","unstructured":"Salvioli, M. et al. Stackelberg evolutionary games of cancer treatment: What treatment strategy to choose if cancer can be stabilized?. Dyn. Games Appl.15, 1750\u20131769. https:\/\/doi.org\/10.1007\/s13235-024-00609-z (2024).","journal-title":"Dyn. Games Appl."},{"key":"33902_CR60","doi-asserted-by":"publisher","unstructured":"Beerling, E., Oosterom, I., Voest, E., Lolkema, M. & van Rheenen, J. Intravital characterization of tumor cell migration in pancreatic cancer. Intravital5, e1261773, https:\/\/doi.org\/10.1080\/21659087.2016.1261773 (2016). Epub 2016 Nov 18.","DOI":"10.1080\/21659087.2016.1261773"},{"key":"33902_CR61","doi-asserted-by":"publisher","unstructured":"Soboleva, A., Kaznatcheev, A., Cavill, R., Schneider, K. & Sta\u0148kov\u00e1, K. Validation of polymorphic Gompertzian model of cancer through in vitro and in vivo data. PLOS ONE20, https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0310844 (2025).","DOI":"10.1371\/JOURNAL.PONE.0310844"},{"key":"33902_CR62","doi-asserted-by":"publisher","unstructured":"Garjani, H., Dubbeldam, J., Sta\u0148kov\u00e1, K. & Brown, J. S. Which evolutionary game-theoretic model best captures NSCLC dynamics? bioRxiv https:\/\/doi.org\/10.1101\/2025.07.10.664060 (2025). https:\/\/www.biorxiv.org\/content\/early\/2025\/07\/15\/2025.07.10.664060.full.pdf.","DOI":"10.1101\/2025.07.10.664060"},{"key":"33902_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011070","volume":"19","author":"CG Cess","year":"2023","unstructured":"Cess, C. G. & Finley, S. D. Calibrating agent-based models to tumor images using representation learning. PLoS Comput. Biol.19, e1011070. https:\/\/doi.org\/10.1371\/journal.pcbi.1011070 (2023).","journal-title":"PLoS Comput. Biol."},{"key":"33902_CR64","doi-asserted-by":"publisher","unstructured":"Rivera, M. et al. Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis. Mol. Biol. Cell33, ar138, https:\/\/doi.org\/10.1091\/mbc.E21-11-0540 (2022).","DOI":"10.1091\/mbc.E21-11-0540"},{"key":"33902_CR65","doi-asserted-by":"publisher","DOI":"10.3791\/52801","volume":"100","author":"E Lonardo","year":"2015","unstructured":"Lonardo, E., Cioffi, M., Sancho, P., Crusz, S. & Heeschen, C. Studying pancreatic cancer stem cell characteristics for developing new treatment strategies. J. Vis. Exp.100, e52801. https:\/\/doi.org\/10.3791\/52801 (2015).","journal-title":"J. Vis. Exp."},{"key":"33902_CR66","doi-asserted-by":"publisher","unstructured":"Nazari, S. S. Generation of 3D tumor spheroids with encapsulating basement membranes for invasion studies. Curr. Protocols Cell Biol.87, https:\/\/doi.org\/10.1002\/cpcb.105 (2020).","DOI":"10.1002\/cpcb.105"},{"key":"33902_CR67","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/cancers16223726","volume":"16","author":"CB Trelford","year":"2024","unstructured":"Trelford, C. B. et al. LKB1 and STRAD$$\\alpha$$ promote epithelial ovarian cancer spheroid cell invasion. Cancers16, 3726. https:\/\/doi.org\/10.3390\/cancers16223726 (2024).","journal-title":"Cancers"},{"key":"33902_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009822","volume":"18","author":"N Ghaffari Laleh","year":"2022","unstructured":"Ghaffari Laleh, N. et al. Classical mathematical models for prediction of response to chemotherapy and immunotherapy. PLoS Comput. Biol.18, e1009822. https:\/\/doi.org\/10.1371\/journal.pcbi.1009822 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"33902_CR69","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cels.2024.04.003","volume":"15","author":"M Strobl","year":"2024","unstructured":"Strobl, M. et al. To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy. Cell Syst.15, 510-525.e6. https:\/\/doi.org\/10.1016\/j.cels.2024.04.003 (2024).","journal-title":"Cell Syst."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33902-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:47:25Z","timestamp":1769680045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33902-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33902-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3929"}}